Please ensure Javascript is enabled for purposes of website accessibility
Inicio > Productos > Anticuerpos > Biosimilares

Anti-Human TRAIL R2/TNFRSF10B Reference Antibody (Conatumumab, RUO) (HT348036)

Anti-Human TRAIL R2/TNFRSF10B Reference Antibody (Conatumumab, RUO)
Anti-Human TRAIL R2/TNFRSF10B Reference Antibody (Conatumumab, RUO)
Anti-Human TRAIL R2/TNFRSF10B Reference Antibody (Conatumumab, RUO)
Anti-Human TRAIL R2/TNFRSF10B Reference Antibody (Conatumumab, RUO)
Anti-Human TRAIL R2/TNFRSF10B Reference Antibody (Conatumumab, RUO)
Anti-Human TRAIL R2/TNFRSF10B Reference Antibody (Conatumumab, RUO)
Anti-Human TRAIL R2/TNFRSF10B Reference Antibody (Conatumumab, RUO)
Anti-Human TRAIL R2/TNFRSF10B Reference Antibody (Conatumumab, RUO)
Anti-Human TRAIL R2/TNFRSF10B Reference Antibody (Conatumumab, RUO)
Anti-Human TRAIL R2/TNFRSF10B Reference Antibody (Conatumumab, RUO)
Anti-Human TRAIL R2/TNFRSF10B Reference Antibody (Conatumumab, RUO)
Anti-Human TRAIL R2/TNFRSF10B Reference Antibody (Conatumumab, RUO)
Precio(USD):
Especificación:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
Número:
Contáctenos
  • Vista general

  • Imágenes

  • Referencias

  • Datasheet

  • SDS

Vista general
Número de catálogoHT348036
Descripción
Conatumumab (HT348036) is a research-grade recombinant antibody targeting CD262. Produced in mammalian cells with native-like glycosylation.
Highlights
  • ●Research Grade — For PK/PD studies, assay development, and ADA research.
  • ●Native Glycosylation — Mammalian expression ensures native-like patterns.
Reactividad de especiesHuman
AplicacionesELISA, Bioactivity: FCM, Functional assay, Research in vivo
Especie huéspedHuman
ClonalidadMonoclonal
IsotipoIgG1-kappa
Aplicaciones probadas WB, FCM
Objetivo CD262, DR5, Death receptor 5, KILLER, TNF-related apoptosis-inducing ligand receptor 2, TNFRSF10B, TRAIL receptor 2, TRAIL-R2, TRAILR2, TRICK2, Tumor necrosis factor receptor superfamily member 10B, ZTNFR9
Nivel de endotoxinas < 10 EU/mg
Pureza >95% as determined by SDS-PAGE.
Purificación Protein A/G purified from cell culture supernatant.
Número de acceso O14763
Forma Liquid
Buffer de almacenamiento 0.01M PBS pH 7.4.

Consulte la información específica del buffer en la copia impresa del datasheet o en el COA específico del lote.

Estabilidad y almacenamiento Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Nombres alternativosAMG655, TRAIL-R2mAb, XG1-048vw, 896731-82-1
Fondo

Tumor necrosis factor receptor superfamily member 10B (CD262/TRAIL-R2) is a ~47 kDa protein. Receptor for the cytotoxic ligand TNFSF10/TRAIL. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. Promotes the activation of NF-kappa-B. Essential for ER stress-induced apoptosis.

1. Hymowitz, SG. et al. (1999) Molecular cell 4, 563-71. PMID: 10549288
Nota For research use only. Not suitable for clinical or therapeutic use.
Isotype Control Human IgG1 Recombinant Isotype Control Antibody (13R4) (HV080507)
Imágenes
  • Anti-Human TRAIL R2/TNFRSF10B Reference Antibody (Conatumumab, RUO)

    Bioactivity

    Detects CD262/TNFRSF10B/TRAIL-R2/DR5 in indirect ELISAs.

  • Anti-Human TRAIL R2/TNFRSF10B Reference Antibody (Conatumumab, RUO)

    SDS-PAGE

    SDS-PAGE for Anti-Human TRAIL R2/TNFRSF10B Reference Antibody (Conatumumab, RUO)

  • Anti-Human TRAIL R2/TNFRSF10B Reference Antibody (Conatumumab, RUO)

    Flow CytoMetry

    Flow-cytometry using APC anti-human CD262 antibody. MDA-MB-231 cells were stained with an irrelevant antibody (Blue Histogram) or an APC anti-human CD262 monoclonal antibody (Catalog: HT348036, Yellow Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, cells analysed on a NovoCyte Flow Cytometer.

  • Anti-Human TRAIL R2/TNFRSF10B Reference Antibody (Conatumumab, RUO)

    Flow CytoMetry

    Flow-cytometry using FITC anti-human CD262 antibody. MDA-MB-231 cells were stained with an irrelevant antibody (Blue Histogram) or an FITC anti-human CD262 monoclonal antibody (Catalog: HT348036, Yellow Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, cells analysed on a NovoCyte Flow Cytometer.

  • Anti-Human TRAIL R2/TNFRSF10B Reference Antibody (Conatumumab, RUO)

    Flow CytoMetry

    Flow-cytometry using PE anti-human CD262 antibody. MDA-MB-231 cells were stained with an irrelevant antibody (Blue Histogram) or an PE anti-human CD262 monoclonal antibody (Catalog: HT348036, Yellow Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, cells analysed on a NovoCyte Flow Cytometer.

  • Anti-Human TRAIL R2/TNFRSF10B Reference Antibody (Conatumumab, RUO)

    Western blot

    Western blot analysis was performed using anti-CD262 monoclonal antibody at 1ug/mL on various samples.
    Lane 1: recombinant human CD262 (Catalog No: HT348011)
    Lane 2: negative control

Referencias
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recomendación

Contáctenos para cotizaciones personalizadas, solicitudes en masa y cualquier otro problema.

Correo: [email protected]

Lista de distribuidores